Poster

Real-World Incidence of Malignancies, Infections and Auto-Immune Diseases in Persons with Rheumatoid Arthritis Treated with Biological vs. Non-Biological Disease-Modifying Antirheumatic Drugs: A systematic Review and Meta-Analysis

Posted on

AUTHORS: Simon T., Kostelec J., Franek J. CONFERENCE: 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management ICPE 2017 DATE: August 26-30, 2017. Objective(s): To perform a systematic literature review to identify publications reporting the rate of malignancies, autoimmune diseases, and infections for BDMARDs vs. NBDMARDs To determine the comparative incidence of immune-related events through meta-analysis See poster […]

Manuscript

Assessing Janus Kinase Inhibitor’s Place in Therapy in Established Rheumatoid Arthritis Patients-From a Simplified Indirect Comparison Versus Tumor Necrosis Factor Inhibitors to a Bayesian Probability of Response-The Value Of Transparency.

Posted on

AUTHORS: Ingham, M.P., Song, P., Cartier, S., Lawson-Remer, K. and Murray, E. Publication: Arthritis and Rheumatism. Vol. 65. 111 River St, Hoboken 07030-5774, Nj Usa: Wiley-Blackwell, 2013. Presented at the 2013 Academy of Managed Care Pharmacy (AMCP) meeting, October 16-18 in San Diego, California. YEAR: 2013 Read article

Presentations

Assessing Janus Kinase Inhibitor’s Place in Therapy in Established Rheumatoid Arthritis Patients-From a Simplified Indirect Comparison Versus Tumor Necrosis Factor Inhibitors to a Bayesian Probability of Response-The Value Of Transparency.

Posted on

AUTHORS: Ingham, M.P., Song, P., Cartier, S., Lawson-Remer, K. and Murray, E. Conference: Academy of Managed Care Pharmacy (AMCP) meeting, San Diego, California. Date: October 16-18, 2013 See presentation